Quotables
"The idea that cavalry will be replaced by these iron coaches is absurd. It is little short of treasonous."
Aide-de-camp to Field Marshal Haig ; At a tank demonstration, 1916
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158811 | Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof The invention relates to unsaturated fatty hydroxy acid derivatives of formula (I), wherein Rn is independent from each other H or linear or branched alkyl group which contain from 1 to 6 carbon atoms and which are possibly substituted by a halogen atom, ... | 04/17/2012 |
| RE42313 | Chemically modified vegetable oil-based industrial fluid Triglyceride oils having unsaturated fatty acid substituents are modified to convert sites of unsaturation to C-2 to C-10 diesters. The resulting derivatives are characterized by thermal and oxidative stability, have low temperature performance properties and are en... | 04/26/2011 |
| 7632957 | Esterification reaction products and cosmetic products An esterification reaction product obtained by esterifying dipentaerythritol and a 12-hydroxystearic acid polymer and having a hydroxyl value of 20 to 70 mg KOH/g and an acid value of 3 mg KOH/g or less. The esterification reaction product has a high-water holding p... | 12/15/2009 |
| 7491836 | Non-ionic surfactants for poorly soluble molecules New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene/alkyl polyoxyalkylene chain with a chain-length of 25-455 repeating units a... | 02/17/2009 |
| 7402610 | Carbonyl compound containing long-chain branched alkyl group A carbonyl compound represented by the following formula [1], wherein X is hydrogen, a hydroxy group, an alkoxy group or a group derived from a polyol, and n, which is the same in each instance, is 4 to 30. Compositions com... | 07/22/2008 |
| 7368125 | Amphiphilic polymers for medical applications The present invention is directed to medical devices or pharmaceutical compositions, each containing a synthetic, bioabsorbable, biocompatible polymer that is the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether. ... | 05/06/2008 |
| 7326426 | Compositions and medical devices utilizing bioabsorbable liquid polymers The present invention is directed to medical devices and pharmaceutical compositions containing a synthetic, bioabsorbable, biocompatible liquid polymer that is the reaction product of a polybasic acid or derivative thereof, a polyol and a fatty acid, the liquid pol... | 02/05/2008 |
| 7288569 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed. ... | 10/30/2007 |
| 7279448 | Poly(hydroxy thioether) vegetable oil derivatives useful as lubricant additives A novel class of chemically-modified vegetable oils is prepared by reacting epoxidized triglyceride oils with thiols. The resultant poly(hydroxy thioether) derivatives have utility as antiwear/antifriction additives for environmentally-friendly industrial oils and a... | 10/09/2007 |
| 7252779 | Transesterification composition of fatty acid esters, and uses thereof This invention is a composition that includes a transesterified fatty acid ester resulting from the reaction of a fatty acid ester, in the presence of an acid, with a hydroxyl-containing compound. The fatty acid esters of the invention are selected from those with a... | 08/07/2007 |
| 7227031 | Prevention of neutrophil recruitment Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II. ... | 06/05/2007 |
| 7101566 | Polymer coated microparticles for sustained release The present invention is directed to sustained release microparticle formulation for parenteral administration of biologically active substances, especially drugs. More specifically it relates to coated drug containing microparticles, wherein the coating is a synthe... | 09/05/2006 |
| 7071150 | Biodegradable lubricating composition and uses thereof, in particular in a bore fluid The invention concerns a biodegradable lubricating composition, based on mineral hydrocarbon oil and ester, comprising a majority amount of a mineral hydrocarbon fraction substantially free of aromatic compounds, said fraction having a normal paraffin content not mo... | 07/04/2006 |
| 7001531 | Sustained release coolant additive composition A coolant additive composition comprising a sustained release component and an additive component, the additive component is effective to provide at least one benefit to a coolant when released into the coolant, the sustained release component includes a polymeric m... | 02/21/2006 |
| 6960674 | Prevention of neutrophil recruitment Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II. ... | 11/01/2005 |
| 6903135 | Methods and products related to 16-HETE analogs The present invention includes 16-HETE analogs which are agonists and antagonists of 16-HETE. The compositions may be formulated in pharmaceutically acceptable formulations. The invention also includes methods and products for inhibiting neutrophil adhesion and neut... | 06/07/2005 |
| 6803385 | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders Hydroxyeicosatetraenoic acid esters and methods of their use in treating dry eye disorders are disclosed. ... | 10/12/2004 |
| 6750360 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed. ... | 06/15/2004 |
| 6710082 | Use of hydroxycarboxylic acid esters as thickeners A thickener composition containing a reaction product of a hydroxycarboxylic acid selected from the group consisting of tartaric acid, malic acid, citric acid and mixtures thereof, and a fatty alcohol polyglycol ether corresponding to formula I: R | 03/23/2004 |
| 6659282 | Prevention of neutrophil recruitment Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.... | 12/09/2003 |
| 6653493 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.... | 11/25/2003 |
| 6639089 | Anticancer agents, perfumes or foods and drinks Anticancer agents containing, as an active ingredient, at least one compound selected from the group consisting of ω-hydroxy fatty acids and salts or esters thereof, hydroxy oxo-fatty acids and salts or esters thereof, lactones, macrocyclic ketones, and ... | 10/28/2003 |
| 6635776 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.... | 10/21/2003 |
| 6620919 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.... | 09/16/2003 |
| 6599972 | Latex compositions containing ethylenically unsaturated esters of fatty compounds and applications thereof Novel latex or emulsion compositions containing internally plasticizing and crosslinkable monomers derived from traditional semi-drying or non-drying oils are disclosed and claimed. The monomers are ethylenically unsaturated derivatives of long-chain olef... | 07/29/2003 |
| 6583302 | Chemically modified vegetable oil-based industrial fluid Triglyceride oils having unsaturated fatty acid substituents are modified to convert sites of unsaturation to C-2 to C-10 diesters. The resulting derivatives are characterized by thermal and oxidative stability, have low temperature performance properties... | 06/24/2003 |
| 6569075 | Lipoxin compounds and their use in treating cell proliferative disorders Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.... | 05/27/2003 |
| 6552084 | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders are disclosed.... | 04/22/2003 |
| 6548609 | Process for the production of oleochemical polyols The present invention is related to an improved process for obtaining oleochemical polyols from oils, principally of a vegetable origin. The polyols obtained consist of a mixture of ethers, esters, primary and secondary alcohols and have the characteristi... | 04/15/2003 |
| 6541061 | Low calorie fat compositions By this invention, low calorie fat compositions comprising the use of acylated glycerides are provided. Of particular interest is the use of triglyceride compositions having a at least one acylated fatty acid. Preferably, the acylated fatty acid has a mel... | 04/01/2003 |
| 6475133 | Methods for making 2-(ω-alkoxycarbonylalkanoyl)-4-butanolide, ester of omega-hydroxy-(ω-3)-ketoaliphatic acid, and derivatives thereof In industrial production of ω-hydroxyaliphatic acid being an important intermediate for large cyclic lactone-based perfumes, using dicarboxylate ester which is inexpensive and readily obtainable, a method, with high yield and improved selectively, for ma... | 11/05/2002 |
| 6441206 | Use of organic acid esters in dietary fat The invention concerns dietary fat compositions that contain the hydroxy acid or dicarboxylic acid or amino acid esters of a phytosterol and/or phytostanol, or the mixed esters formed with the alcohols, polyols or polyol (C2 . . . C22 | 08/27/2002 |
| 6433202 | Prevention of neutrophil recruitment Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.... | 08/13/2002 |
| 6420596 | Process for the selective esterification of tertiary alcohol by an acid anhydride using a reusable solid catalyst This invention provides a process for the selective esterfication of a tertiary alcohol(I) by an acid anhydride(II) to produce corresponding tertiary ester(III) and carboxylic acid(V), using a reusable solid catalyst(IV) comprising one or more halides of ... | 07/16/2002 |
| 6407272 | Secondary alcohol esters of hydroxyacids and uses thereof Secondary alcohol esters of hydroxyacids, e.g., ricinoleate esters of secondary alcohols, are prepared by reacting an ester of a hydroxyacid with a secondary alcohol, in the presence of an organometallic transesterification catalyst. Under these reaction ... | 06/18/2002 |
| 6376688 | Modified polyunsaturated fatty acids The present invention provides polyunsaturated fatty acid compounds having antimalarial and/or neutrophil stimulatory activity. The polyunsaturated fatty acids contain 18-25 carbons and 1-6 double bonds and are characterized in that they have one or two s... | 04/23/2002 |
| 6369248 | Fragrance precursor compounds Compounds having formula (I) in which n is 1, 2 or 3 and R1 to R6 represent, independently, branched or unbranched, substituted or unsubstituted alkyl-, alkenyl-, alkinyl-, cycloalkyl-, cycloalkenyl- or aromatic-radicals or hydrogen ... | 04/09/2002 |
| 6365628 | Fatty analogues for the treatment of diabetes The present invention relates to novel fatty acid analogues of the general formula (I): CH3 --[CH2 ]m --[xi --CH2 ]n --COOR, as defined in the specification, which can be used for the treat... | 04/02/2002 |
| 6359158 | Methods and products related to 16-HETE analogs The present invention includes 16-HETE analogs which are agonists and antagonists of 16-HETE. The compositions may be formulated in pharmaceutically acceptable formulations. The invention also includes methods and products for inhibiting neutrophil adhesi... | 03/19/2002 |
| 6326499 | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye Omega chain modified 15-HETE derivatives and methods of their use for treating dry eye are disclosed.... | 12/04/2001 |
